Isolation of C. difficile carriers alone and as part of a bundle approach for the prevention of Clostridium Difficile Infection (CDI): A mathematical model based on clinical study data

PLoS ONE

Volumn 11, Issue 6, 2016, Pages

  Grigoras, Christos A ^a,b   Zervou, Fainareti N ^a   Zacharioudakis, Ioannis M ^a   Siettos, Constantinos I ^b   Mylonakis, Eleftherios ^a  

^a BROWN UNIVERSITY   (United States)

^b NATIONAL TECHNICAL UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL COLONIZATION; BACTERIAL TRANSMISSION; BACTERIUM CARRIER; CLINICAL PRACTICE; CLOSTRIDIUM DIFFICILE INFECTION; HEALTH CARE POLICY; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL INFECTION; HUMAN; INCIDENCE; INFECTION CONTROL; MATHEMATICAL MODEL; PATIENT ISOLATION; PROBABILITY; RISK REDUCTION; SCREENING TEST; STOCHASTIC MODEL; UNITED STATES; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; HETEROZYGOTE; HOSPITALIZATION; ISOLATION AND PURIFICATION; MARKOV CHAIN; PEPTOCLOSTRIDIUM DIFFICILE; PREVALENCE; PREVENTION AND CONTROL; THEORETICAL MODEL;

ANTIINFECTIVE AGENT;

ANTI-INFECTIVE AGENTS; CARRIER STATE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; HOSPITALIZATION; HUMANS; INCIDENCE; MODELS, THEORETICAL; PATIENT ADMISSION; PREVALENCE; PROBABILITY; STOCHASTIC PROCESSES;

EID: 84973505625     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0156577     Document Type: Article

References (48)

1. Magill SS, Edwards JR, Bamberg W, Beldavs ZG, Dumyati G, Kainer MA, et al. Multistate point-prevalence survey of health care-associated infections. The New England journal of medicine. 2014; 370(13):1198-208. doi: 10.1056/NEJMoa1306801 PMID: 24670166.
2. Bauer MP, Notermans DW, van Benthem BH, Brazier JS, Wilcox MH, Rupnik M, et al. Clostridium difficile infection in Europe: a hospital-based survey. Lancet. 2011; 377(9759):63-73. Epub 2010/11/19. doi: 10.1016/s0140-6736(10)61266-4 PMID: 21084111.
3. Lessa FC, Mu Y, Bamberg WM, Beldavs ZG, Dumyati GK, Dunn JR, et al. Burden of Clostridium difficile infection in the United States. The New England journal of medicine. 2015; 372(9):825-34. doi: 10.1056/NEJMoa1408913 PMID: 25714160.
4. Dubberke ER, Olsen MA. Burden of Clostridium difficile on the healthcare system. Clin Infect Dis. 2012;55 Suppl 2:S88-92. Epub 2012/07/07. doi: 10.1093/cid/cis335 PMID: 22752870; PubMed Central PMCID: PMCPMC3388018.
5. Freeman J, Bauer MP, Baines SD, Corver J, Fawley WN, Goorhuis B, et al. The changing epidemiology of Clostridium difficile infections. Clin Microbiol Rev. 2010; 23(3):529-49. Epub 2010/07/09. doi: 10.1128/cmr.00082-09 PMID: 20610822; PubMed Central PMCID: PMCPMC2901659.
6. Riggs MM, Sethi AK, Zabarsky TF, Eckstein EC, Jump RL, Donskey CJ. Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents. Clin Infect Dis. 2007; 45(8):992-8. Epub 2007/09/21. doi: 10.1086/521854 PMID: 17879913.
7. Yokoe DS, Anderson DJ, Berenholtz SM, Calfee DP, Dubberke ER, Ellingson KD, et al. A compendium of strategies to prevent healthcare-associated infections in acute care hospitals: 2014 updates. Infect Control Hosp Epidemiol. 2014; 35 Suppl 2:S21-31. PMID: 25376067.
8. Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol. 2010; 31(5):431-55. Epub 2010/03/24. doi: 10.1086/651706 PMID: 20307191.
9. Surawicz CM, Brandt LJ, Binion DG, Ananthakrishnan AN, Curry SR, Gilligan PH, et al. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol. 2013; 108(4):478-98; quiz 99. doi: 10.1038/ajg.2013.4 PMID: 23439232.
10. Deshpande A, Pant C, Pasupuleti V, Rolston DD, Jain A, Deshpande N, et al. Association between proton pump inhibitor therapy and Clostridium difficile infection in a meta-analysis. Clin Gastroenterol Hepatol. 2012; 10(3):225-33. Epub 2011/10/25. doi: 10.1016/j.cgh.2011.09.030 PMID: 22019794.
11. Deshpande A, Pasupuleti V, Thota P, Pant C, Rolston DDK, Sferra TJ, et al. Community-associated Clostridium difficile infection and antibiotics: a meta-analysis. Journal of Antimicrobial Chemotherapy. 2013. doi: 10.1093/jac/dkt129
12. Deshpande A, Pant C, Jain A, Fraser TG, Rolston DD. Do fluoroquinolones predispose patients to Clostridium difficile associated disease? A review of the evidence. Curr Med Res Opin. 2008; 24(2):329-33. Epub 2007/12/11. doi: 10.1185/030079908x253735 PMID: 18067688.
13. Donskey CJ, Kundrapu S, Deshpande A. Colonization versus carriage of Clostridium difficile. Infect Dis Clin North Am. 2015; 29(1):13-28. Epub 2015/01/18. doi: 10.1016/j.idc.2014.11.001 PMID: 25595843.
14. Galdys AL, Curry SR, Harrison LH. Asymptomatic Clostridium difficile colonization as a reservoir for Clostridium difficile infection. Expert Rev Anti Infect Ther. 2014; 12(8):967-80. doi: 10.1586/14787210.2014.920252 PMID: 24848084.
15. Curry SR, Muto CA, Schlackman JL, Pasculle AW, Shutt KA, Marsh JW, et al. Use of multilocus variable number of tandem repeats analysis genotyping to determine the role of asymptomatic carriers in Clostridium difficile transmission. Clin Infect Dis. 2013; 57(8):1094-102. Epub 2013/07/25. doi: 10.1093/cid/cit475 PMID: 23881150; PubMed Central PMCID: PMCPMC3783061.
16. Loo VG, Bourgault AM, Poirier L, Lamothe F, Michaud S, Turgeon N, et al. Host and pathogen factors for Clostridium difficile infection and colonization. The New England journal of medicine. 2011; 365(18):1693-703. Epub 2011/11/04. doi: 10.1056/NEJMoa1012413 PMID: 22047560.
17. Zacharioudakis IM, Zervou FN, Pliakos EE, Ziakas PD, Mylonakis E. Colonization with toxinogenic C. difficile upon hospital admission, and risk of infection: a systematic review and meta-analysis. Am J Gastroenterol. 2015; 110(3):381-90; quiz 91. Epub 2015/03/04. doi: 10.1038/ajg.2015.22 PMID: 25732416.
18. Lucado J, Gould C, Elixhauser A. Clostridium Difficile Infections (CDI) in Hospital Stays, 2009: Statistical Brief #124. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Rockville MD2006.
19. Alasmari F, Seiler SM, Hink T, Burnham C-AD, Dubberke ER. Prevalence and Risk Factors for Asymptomatic Clostridium difficile Carriage. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 2014; 59(2):216-22. doi: 10.1093/cid/ciu258 PMID: PMC4133563.
20. Reveles KR, Lee GC, Boyd NK, Frei CR. The rise in Clostridium difficile infection incidence among hospitalized adults in the United States: 2001-2010. Am J Infect Control. 2014; 42(10):1028-32. Epub 2014/10/04. doi: 10.1016/j.ajic.2014.06.011 PMID: 25278388.
21. Kyne L, Warny M, Qamar A, Kelly CP. Asymptomatic Carriage of Clostridium difficile and Serum Levels of IgG Antibody against Toxin A. New England Journal of Medicine. 2000; 342(6):390-7. doi: 10.1056/NEJM200002103420604 PMID: 10666429.
22. McFarland LV, Mulligan ME, Kwok RY, Stamm WE. Nosocomial acquisition of Clostridium difficile infection. The New England journal of medicine. 1989; 320(4):204-10. Epub 1989/01/26. doi: 10.1056/nejm198901263200402 PMID: 2911306.
23. O'Brien JA, Lahue BJ, Caro JJ, Davidson DM. The emerging infectious challenge of clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences. Infect Control Hosp Epidemiol. 2007; 28(11):1219-27. Epub 2007/10/11. doi: 10.1086/522676 PMID: 17926270.
24. Dubberke ER, Butler AM, Reske KA, Agniel D, Olsen MA, D'Angelo G, et al. Attributable outcomes of endemic Clostridium difficile-associated disease in nonsurgical patients. Emerging infectious diseases. 2008; 14(7):1031-8. Epub 2008/07/05. doi: 10.3201/eid1407.070867 PMID: 18598621; PubMed Central PMCID: PMCPMC2600322.
25. Weiss AJ, Elixhauser A. Overview of Hospital Stays in the United States, 2012: Statistical Brief #180. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Rockville (MD): Agency for Health Care Policy and Research (US); 2012.
26. Lanzas C, Dubberke ER. Effectiveness of screening hospital admissions to detect asymptomatic carriers of Clostridium difficile: a modeling evaluation. Infect Control Hosp Epidemiol. 2014; 35(8):1043-50. Epub 2014/07/16. doi: 10.1086/677162 PMID: 25026622.
27. Lanzas C, Dubberke ER, Lu Z, Reske KA, Grohn YT. Epidemiological model for Clostridium difficile transmission in healthcare settings. Infect Control Hosp Epidemiol. 2011; 32(6):553-61. Epub 2011/05/12. doi: 10.1086/660013 PMID: 21558767; PubMed Central PMCID: PMCPMC3645005.
28. Yakob L, Riley TV, Paterson DL, Clements AC. Clostridium difficile exposure as an insidious source of infection in healthcare settings: an epidemiological model. BMC Infect Dis. 2013; 13:376. Epub 2013/08/21. doi: 10.1186/1471-2334-13-376 PMID: 23947736; PubMed Central PMCID: PMCPMC3751620.
29. Yakob L, Riley TV, Paterson DL, Marquess J, Clements AC. Assessing control bundles for Clostridium difficile: a review and mathematical model. Emerg Microbes Infect. 2014; 3(6):e43. Epub 2015/06/04. doi: 10.1038/emi.2014.43 PMID: 26038744; PubMed Central PMCID: PMCPMC4078791.
30. Keeling MJ. Modeling infectious diseases in humans and animals. In: Rohani P, editor. Princeton:: Princeton University Press; 2008.
31. Kundrapu S, Sunkesula VC, Jury LA, Sethi AK, Donskey CJ. Utility of perirectal swab specimens for diagnosis of Clostridium difficile infection. Clin Infect Dis. 2012; 55(11):1527-30. Epub 2012/08/23. doi: 10.1093/cid/cis707 PMID: 22911648.
32. Deshpande A, Pasupuleti V, Rolston DDK, Jain A, Deshpande N, Pant C, et al. Diagnostic Accuracy of Real-time Polymerase Chain Reaction in Detection of Clostridium difficile in the Stool Samples of Patients With Suspected Clostridium difficile Infection: A Meta-Analysis. Clinical Infectious Diseases. 2011; 53(7):e81-e90. doi: 10.1093/cid/cir505 PMID: 21890762
33. O'Horo JC, Jones A, Sternke M, Harper C, Safdar N. Molecular techniques for diagnosis of Clostridium difficile infection: systematic review and meta-analysis. Mayo Clin Proc. 2012; 87(7):643-51. Epub 2012/07/07. doi: 10.1016/j.mayocp.2012.02.024 PMID: 22766084; PubMed Central PMCID: PMCPMC3538482.
34. Dhar S, Marchaim D, Tansek R, Chopra T, Yousuf A, Bhargava A, et al. Contact precautions: more is not necessarily better. Infect Control Hosp Epidemiol. 2014; 35(3):213-21. Epub 2014/02/14. doi: 10.1086/675294 PMID: 24521583.
35. Simor AE, Williams V, McGeer A, Raboud J, Larios O, Weiss K, et al. Prevalence of colonization and infection with methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus and of Clostridium difficile infection in Canadian hospitals. Infect Control Hosp Epidemiol. 2013; 34(7):687-93. Epub 2013/06/07. doi: 10.1086/670998 PMID: 23739072.
36. Feazel LM, Malhotra A, Perencevich EN, Kaboli P, Diekema DJ, Schweizer ML. Effect of antibiotic stewardship programmes on Clostridium difficile incidence: a systematic review and meta-analysis. The Journal of antimicrobial chemotherapy. 2014; 69(7):1748-54. Epub 2014/03/19. doi: 10.1093/jac/dku046 PMID: 24633207.
37. Cook PP, Gooch M. Long-term effects of an antimicrobial stewardship programme at a tertiary-care teaching hospital. International journal of antimicrobial agents. 2015; 45(3):262-7. Epub 2015/01/03. doi: 10.1016/j.ijantimicag.2014.11.006 PMID: 25554468.
38. Starr JM, Campbell A, Renshaw E, Poxton IR, Gibson GJ. Spatio-temporal stochastic modelling of Clostridium difficile. J Hosp Infect. 2009; 71(1):49-56. Epub 2008/11/18. doi: 10.1016/j.jhin.2008.09.013 PMID: 19013677.
39. Forster AJ, Taljaard M, Oake N, Wilson K, Roth V, van Walraven C. The effect of hospital-acquired infection with Clostridium difficile on length of stay in hospital. CMAJ. 2012; 184(1):37-42. doi: 10.1503/cmaj.110543 PMID: 22143235; PubMed Central PMCID: PMC3255231.
40. Leekha S, Aronhalt KC, Sloan LM, Patel R, Orenstein R. Asymptomatic Clostridium difficile colonization in a tertiary care hospital: admission prevalence and risk factors. American journal of infection control. 2013; 41(5):390-3. Epub 2013/04/30. doi: 10.1016/j.ajic.2012.09.023 PMID: 23622704.
41. Guerrero DM, Becker JC, Eckstein EC, Kundrapu S, Deshpande A, Sethi AK, et al. Asymptomatic carriage of toxigenic Clostridium difficile by hospitalized patients. J Hosp Infect. 2013; 85(2):155-8. Epub 2013/08/21. doi: 10.1016/j.jhin.2013.07.002 PMID: 23954113.
42. Morgan DJ, Pineles L, Shardell M, Graham MM, Mohammadi S, Forrest GN, et al. The effect of contact precautions on healthcare worker activity in acute care hospitals. Infection control and hospital epidemiology. 2013; 34(1):69-73. Epub 2012/12/12. doi: 10.1086/668775 PMID: 23221195.
43. Yanke E, Zellmer C, Van Hoof S, Moriarty H, Carayon P, Safdar N. Understanding the current state of infection prevention to prevent Clostridium difficile infection: a human factors and systems engineering approach. American journal of infection control. 2015; 43(3):241-7. Epub 2015/03/03. doi: 10.1016/j.ajic.2014.11.026 PMID: 25728149; PubMed Central PMCID: PMCPmc4465332.
44. Shim JK, Johnson S, Samore MH, Bliss DZ, Gerding DN. Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea. Lancet. 1998; 351(9103):633-6. Epub 1998/03/21. doi: 10.1016/s0140-6736(97)08062-8 PMID: 9500319.
45. Rodriguez C, Korsak N, Taminiau B, Avesani V, Van Broeck J, Delmee M, et al. Clostridium difficile infection in elderly nursing home residents. Anaerobe. 2014; 30:184-7. Epub 2014/08/26. doi: 10.1016/j.anaerobe.2014.08.007 PMID: 25152228.
46. Johnston BC, Ma SS, Goldenberg JZ, Thorlund K, Vandvik PO, Loeb M, et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea: a systematic review and meta-analysis. Ann Intern Med. 2012; 157(12):878-88. Epub 2013/01/31. PMID: 23362517.
47. Austin M, Mellow M, Tierney WM. Fecal microbiota transplantation in the treatment of Clostridium difficile infections. Am J Med. 2014; 127(6):479-83. Epub 2014/03/04. doi: 10.1016/j.amjmed.2014.02.017 PMID: 24582877.
48. Allen SJ, Wareham K, Wang D, Bradley C, Hutchings H, Harris W, et al. Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2013; 382(9900):1249-57. Epub 2013/08/13. doi: 10.1016/s0140-6736(13)61218-0 PMID: 23932219.